Our life-science industry partners

Our position on working with the pharmaceutical sector

Collaborations between charities and support groups representing people living with rare, genetic and undiagnosed conditions and the life-sciences industry can deliver significant benefits by: 

• Helping industry partners to understand what matters most for people living with rare, genetic and undiagnosed conditions and their families; 
• Improving how existing screening technologies, diagnostic tests, treatments and therapies are used to improve health and quality of life;
• Speeding up the development of new screening technologies, diagnostic tests, treatments and therapies.

For more information on how and why we work with the life-sciences industry, read our Policy on working with the life-sciences industry. 

Our current policy was approved in 2023 and it commits us to publish an overview of the funding received from the life-sciences industry in our Annual Report and Accounts each year. Overviews of funding received during the past two financial years are published here for transparency.

If you are a life-sciences company interested in supporting our work, please contact our Corporate Partnerships Manager Justin Khodaiji at [email protected]